A Secret Weapon For LY 3000328
Other clinical trials in individuals with non-Hodgkin's lymphoma [24] and sufferers with State-of-the-art malignancy [fourteen] have shown also that zosuquidar didn't appreciably have an effect on the pharmacokinetics of doxorubicin and had average outcomes around the pharmacokinetics of vincristine. These scientific trials accredited that zosuquid